Biogen Inc (NASDAQ:BIIB)
| 212.57 Delayed Data As of 4:00pm ET |  +1.93 / +0.92%Today’s Change | 187.16 Today|||52-Week Range 372.12 | -11.40% Year-to-Date |
Latest BIIB News | Press Releases
No recent news for Biogen Inc.
Today’s Trading
| Previous close | 210.64 |
| Today’s open | 209.19 |
| Day’s range | 206.78 - 212.67 |
| Volume | 24,558 |
| Average volume (3 months) | 1,119,356 |
| Market cap | $30.8B |
Data as of 4:00pm ET, 07/05/2022
Growth & Valuation
| Earnings growth (last year) | -58.03% |
| Earnings growth (this year) | -19.68% |
| Earnings growth (next 5 years) | -7.00% |
| Revenue growth (last year) | -15.81% |
| P/E ratio | 21.8 |
| Price/Sales | 3.45 |
| Price/Book | 2.84 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | +2.32 | +1.21% |
| ---- | ||
| BMRNBiomarin Pharmaceuti... | +1.33 | +1.56% |
| TECHBio-Techne Corp | +9.35 | +2.65% |
Data as of 4:01pm ET, 07/05/2022
Financials
| Next reporting date | July 26, 2022 |
| EPS forecast (this quarter) | $4.11 |
| Annual revenue (last year) | $10.4B |
| Annual profit (last year) | $1.6B |
| Net profit margin | 14.96% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
